BeOne Medicines

BeOne Medicines To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.

BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them. We all share the responsibility to report adverse events observed with our products so that they may be investigated, actioned, and communicated accordingly. To report an adverse event or side effect, please talk to your healthcare provider and contact us here: https://beonemedicines.com/contact-us/report-adverse-events/

10/29/2025

From coast to coast, Team BeOne joined communities to bring light to the darkness of blood cancer – honoring survivors, remembering loved ones, and standing with patients and families.

As the National Presenting Sponsor of Survivorship and Hope for Blood Cancer United's , BeOne is honored to help advance vital research, expand patient services, and strengthen advocacy that make a lasting difference for people impacted by blood cancer.

10/28/2025

15 years of BeOne – and still moving with purpose.

We’re proud of how far we’ve come as a team, and even more excited for what’s ahead. Together, we are how the world stops cancer.

As  , we strive to challenge the status quo to deliver science once thought to be impossible.Meet Nicole Teichmann, Clin...
10/24/2025

As , we strive to challenge the status quo to deliver science once thought to be impossible.

Meet Nicole Teichmann, Clinical Study Manager, who reflects on the positive atmosphere within the team that fuels the company's growth.

Interested in exploring career opportunities? Visit https://ow.ly/NNH250XgXPM.

10/23/2025

In case you missed it, our latest Cancer Has No Borders episode highlights The Max Foundation mission to ensure patients all over the world can access cancer treatment – helping 100,000+ people over 27 years. Check out the full episode here: https://ow.ly/MXjA50XgXqP

We look forward to supporting Lymphoma Research Foundation's upcoming webinar, Update on Mantle Cell Lymphoma, taking pl...
10/20/2025

We look forward to supporting Lymphoma Research Foundation's upcoming webinar, Update on Mantle Cell Lymphoma, taking place Wednesday, October 22, from 1–2 PM ET.

This free, virtual program will cover the symptoms, diagnosis, and treatment of , including targeted therapies, immunotherapies, and emerging treatments, plus quality-of-life considerations and an interactive Q&A with experts.

Learn more and register here: https://ow.ly/3wFn50Xf90l

New Episode of the Cancer Has No Borders Podcast!What began as one mother’s heartbreak became a global movement of hope....
10/07/2025

New Episode of the Cancer Has No Borders Podcast!

What began as one mother’s heartbreak became a global movement of hope.

In this inspiring episode, Zachary Randles-Friedman sits down with Pat Garcia-Gonzalez, the visionary CEO and co-founder of The Max Foundation who turned the loss of her 17-year-old stepson, Max, into a worldwide mission to ensure cancer patients in low-resource countries can access lifesaving treatment.

Pat and her team have helped more than 100,000 patients across 80+ countries—delivering not just medicine, but dignity, education, and hope to families facing impossible odds.

Listen now:

YouTube: https://ow.ly/pF1g50X7VcK
Apple: https://ow.ly/NSXZ50X7VcI
Spotify: https://ow.ly/oaEX50X7VcJ
Amazon: https://ow.ly/slgk50X7VcG

Learn more about The Max Foundation at https://ow.ly/fuH350X7VcH

In this powerful episode of The Cancer Has No Borders podcast, host Zach Randles-Friedman sits down with Pat García-González, co-founder and CEO of The Max F...

At BeOne, our commitment to patients goes beyond innovation. We believe in the power of partnerships to elevate patient ...
10/03/2025

At BeOne, our commitment to patients goes beyond innovation. We believe in the power of partnerships to elevate patient voices, expand access, and co-create solutions that improve lives.

This , we’re spotlighting key patient advocacy partners, including Living Beyond Breast Cancer, Tigerlily Foundation, and Susan G. Komen, alongside the broader community working every day to support and empower people impacted by breast cancer.

Let’s learn, share, and advocate together.

09/30/2025

As Blood Cancer Awareness Month comes to a close, we continue to honor the patients, families, caregivers, advocates, and clinicians who inspire us every day.

At BeOne, our commitment doesn’t end in September. From advancing science with purpose, to expanding access across geographies, to keeping patients at the center of all we do — we are working together to help close the gaps in blood cancer care.

Watch this short video featuring our leaders from around the world, reflecting on how we’re making an impact — today, tomorrow, and every day.

We are honored to support Cancer Support Community’s pre-conference at the Native Cancer Conference, hosted by the Ameri...
09/29/2025

We are honored to support Cancer Support Community’s pre-conference at the Native Cancer Conference, hosted by the American Indian Cancer Foundation. This important gathering shines a light on access, quality of care, and culturally grounded solutions to address cancer inequities in the Native American community. These conversations are vital to building trust, expanding access, and ensuring that every patient has the opportunity for quality care.

We’re thrilled to partner with the American Indian Cancer Foundation to offer a free pre-conference to their annual Native Cancer Conference. Hosted at the Radisson Blu Mall of America in Minnesota on Monday, November 3rd, the pre-conference will feature a multi-disciplinary group of leaders and experts discussing crucial concerns including access and payment models with quality of care as a central theme.

We encourage all interested in attending the pre-conference and the Native Cancer Conference to follow to visit the link below to learn more.

We thank BeOne Medicines for their support of CSC’s pre-conference and AstraZeneca for their support of the .

betterunite.com/nativecancerconference

Meet Vanessa Morais, Quality Senior Manager, who’s personal experience with cancer provides a unique perspective within ...
09/25/2025

Meet Vanessa Morais, Quality Senior Manager, who’s personal experience with cancer provides a unique perspective within her role.

We’re proud to be part of , who takes a stand against cancer and strives to challenge the status quo to deliver science previously thought to be impossible.

Interested in joining us? Visit https://ow.ly/pWFP50X29Cr.

09/24/2025

For CLL patients, the phrase 'watch and wait' can create anxiety and uncertainty during active monitoring. At BeOne, we are dedicated to ensuring that patients with Chronic Lymphocytic Leukemia (CLL) and their caregivers have access to clear and credible information.

Collaborating with our panel of experts, including Jan Geissler, Christina Karamanidou, Jana Pelouchova, Lydia Scarfo & Peter Haggert, we came together to tackle the pressing challenges faced by the CLL community. As key contributors to the CLL Call-To-Action Report, the panel explored critical areas of unmet need and innovative approaches to care, placing a strong emphasis on the emotional and practical support required to navigate active monitoring.

Watch the full discussion to learn how you can take actionable steps to enhance the lives of people living with CLL: https://youtu.be/5D2zaDc2ISc

09/17/2025

"When my patients hear the word 'cancer,' the shutters come down."

For Dr. Kennedy, a dedicated hematologist, effective communication is key to helping patients navigate the complexities of Chronic Lymphocytic Leukemia (CLL). The anxiety felt during CLL diagnosis can be significantly decreased when patients have a clear understanding of CLL and the support available to them.

"Without good, trusted information, patients can become overwhelmed with worry." How healthcare providers present and discuss information greatly affects how patients feel when they leave the consultation room—either empowered, ready to take action and thrive, or worried, scared, and uncertain about their future.

Discover Dr. Kennedy's insights gained from working with CLL patients and discover the Call-to-Action Report, developed in partnership with CLL Advocates Network, to highlight the unmet needs in their care: https://ow.ly/8vHF50WXO6x

Address

55 Cambridge Parkway, Suite 700W
Cambridge, MA
02142

Website

https://www.linkedin.com/company/beonemedicines

Alerts

Be the first to know and let us send you an email when BeOne Medicines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram